Plasma folate concentrations are positively associated with risk of estrogen receptor β negative breast cancer in a Swedish nested case control study

Journal of Nutrition

Volumn 140, Issue 9, 2010, Pages 1661-1668

  Ericson, Ulrika ^a   Borgquist, Signe ^a   Ivarsson, Malin I L ^a   Sonestedt, Emily ^a   Gullberg, Bo ^a   Carlson, Joyce ^a   Olsson, Håkan ^a   Jirström, Karin ^a   Wirfält, Elisabet ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR BETA; FOLIC ACID;

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; VITAMIN SUPPLEMENTATION;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR BETA; FEMALE; FOLIC ACID; HUMANS; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POSTMENOPAUSE; RISK FACTORS; SWEDEN;

EID: 77956594364     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.110.124313     Document Type: Article

References (50)

1. Kim YI. Folate: a magic bullet or a double edged sword for colorectal cancer prevention? Gut. 2006;55:1387-9.
2. Kim YI. Nutritional epigenetics: impact of folate deficiency on DNA methylation and colon cancer susceptibility. J Nutr. 2005;135:2703-9.
3. Drogan D, Klipstein-Grobusch K, Wans S, Luley C, Boeing H, Dierkes J. Plasma folate as marker of folate status in epidemiological studies: The European Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr. 2004;92:489-96. (Pubitemid 40277070)
4. Blount BC, Mack MM, Wehr CM, MacGregor JT, Hiatt RA, Wang G, Wickramasinghe SN, Everson RB, Ames BN. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA. 1997;94:3290-5. (Pubitemid 27157304)
5. Mason JB. Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J Nutr. 2003;133 Suppl 3:S941-7.
6. Ma J, Stampfer MJ, Hennekens CH, Frosst P, Selhub J, Horsford J, Malinow MR, Willett WC, Rozen R. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in us physicians. Circulation. 1996;94:2410-6. (Pubitemid 26403566)
7. Ericson UC, Ivarsson MI, Sonestedt E, Gullberg B, Carlson J, Olsson H, Wirfalt E. Increased breast cancer risk at high plasma folate concentrations among women with the MTHFR 677t allele. Am J Clin Nutr. 2009;90:1380-9.
8. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet. 1998;62:1044-51.
9. Zetterberg H, Regland B, Palmer M, Ricksten A, Palmqvist L, Rymo L, Arvanitis DA, Spandidos DA, Blennow K. Increased frequency of combined methylenetetrahydrofolate reductase c677t and a1298c mutated alleles in spontaneously aborted embryos. Eur J Hum Genet. 2002;10:113-8. (Pubitemid 34414045)
10. Chen J, Ma J, Stampfer MJ, Palomeque C, Selhub J, Hunter DJ. Linkage disequilibrium between the 677c>t and 1298a>c polymorphisms in human methylenetetrahydrofolate reductase gene and their contributions to risk of colorectal cancer. Pharmacogenetics. 2002;12:339-42. (Pubitemid 34620663)
11. Mao R, Fan Y, Chen F, Sun D, Bai J, Fu S. Methylenetetrahydrofolate reductase gene polymorphisms in 13 Chinese ethnic populations. Cell Biochem Funct. 2008;26:352-8. (Pubitemid 351613177)
12. Larsson SC, Giovannucci E, Wolk A. Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst. 2007;99:64-76.
13. Lissowska J, Gaudet MM, Brinton LA, Chanock SJ, Peplonska B, Welch R, Zatonski W, Szeszenia-Dabrowska N, Park S, et al. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer. 2007;120:2696-703.
14. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys SS, Hoover RN, Ziegler RG. Folate intake, alcohol use, and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Clin Nutr. 2006;83:895-904. (Pubitemid 44713156)
15. Zhu K, Williams SM. Methyl-deficient diets, methylated er genes and breast cancer: an hypothesized association. Cancer Causes Control. 1998;9:615-20. (Pubitemid 29046134)
16. Larsson SC, Bergkvist L, Wolk A. Folate intake and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort. Cancer Epidemiol Biomarkers Prev. 2008;17:3444-9.
17. Lin J, Lee IM, Cook NR, Selhub J, Manson JE, Buring JE, Zhang SM. Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women. Am J Clin Nutr. 2008;87:734-43.
18. Maruti SS, Ulrich CM, White E. Folate and one-carbon metabolism nutrients from supplements and diet in relation to breast cancer risk. Am J Clin Nutr. 2009;89:624-33.
19. Sellers TA, Vierkant RA, Cerhan JR, Gapstur SM, Vachon CM, Olson JE, Pankratz VS, Kushi LH, Folsom AR. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2002;11:1104-7.
20. Zhang SM, Hankinson SE, Hunter DJ, Giovannucci EL, Colditz GA, Willett WC. Folate intake and risk of breast cancer characterized by hormone receptor status. Cancer Epidemiol Biomarkers Prev. 2005;14: 2004-8.
21. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustafsson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA. 1996;93:5925-30. (Pubitemid 26190778)
22. Manjer J, Carlsson S, Elmstahl S, Gullberg B, Janzon L, Lindstrom M, Mattisson I, Berglund G. The Malmo diet and cancer study: representativity, cancer incidence and mortality in participants and nonparticipants. Eur J Cancer Prev. 2001;10:489-99. (Pubitemid 34048904)
23. Callmer E, Riboli E, Saracci R, Akesson B, Lindgarde F. Dietary assessment methods evaluated in the Malmo food study. J Intern Med. 1993;233:53-7.
24. Wirfalt E, Mattisson I, Johansson U, Gullberg B, Wallstrom P, Berglund G. A methodological report from the malmo diet and cancer study: development and evaluation of altered routines in dietary data processing. Nutr J. 2002;1:3.
25. Pero RW, Olsson A, Berglund G, Janzon L, Larsson SA, Elmstahl S. The Malmo biological bank. J Intern Med. 1993;233:63-7.
26. Ericson U, Sonestedt E, Ivarsson MI, Gullberg B, Carlson J, Olsson H, Wirfalt E. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmo diet and cancer cohort. Cancer Epidemiol Biomarkers Prev. 2009;18:1101-10.
27. Fuqua SA, Schiff R, Parra I, Friedrichs WE, Su JL, McKee DD, Slentz-Kesler K, Moore LB, Willson TM, et al. Expression of wild-type estrogen receptor beta and variant isoforms in human breast cancer. Cancer Res. 1999;59:5425-8.
28. Elmståhl S, Wallstro̊m P, Berglund G, Janzon L, Johansson U, Larsson SA, Mattisson I. The use of dietary supplements in relation to dietary habits in a Swedish middle-aged population. Scand J Nutr. 1994;38: 94-7.
29. Riboli E, Elmstahl S, Saracci R, Gullberg B, Lindgarde F. The Malmo food study: validity of two dietary assessment methods for measuring nutrient intake. Int J Epidemiol. 1997;26 Suppl 1:S161-73.
30. Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986;124:17-27.
31. Merlo J, Berglund G, Wirfalt E, Gullberg B, Hedblad B, Manjer J, Hovelius B, Janzon L, Hanson BS, et al. Self-administered questionnaire compared with a personal diary for assessment of current use of hormone therapy: an analysis of 16,060 women. Am J Epidemiol. 2000;152:788-92.
32. Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MR, Hanby AM. Oestrogen receptor beta: what it means for patients with breast cancer. Lancet Oncol. 2004;5:174-81.
33. Zhu K, Davidson NE, Hunter S, Yang X, Payne-Wilks K, Roland CL, Phillips D, Bentley C, Dai M, et al. Methyl-group dietary intake and risk of breast cancer among African-American women: a case-control study by methylation status of the estrogen receptor alpha genes. Cancer Causes Control. 2003;14:827-36.
34. Smith AD, Kim YI, Refsum H. Is folic acid good for everyone? Am J Clin Nutr. 2008;87:517-33.
35. Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation. Oncogene. 2003;22:7600-6.
36. Skliris GP, Munot K, Bell SM, Carder PJ, Lane S, Horgan K, Lansdown MR, Parkes AT, Hanby AM, et al. Reduced expression of oestrogen receptor beta in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J Pathol. 2003;201: 213-20.
37. Borgquist S, Holm C, Stendahl M, Anagnostaki L, Landberg G, Jirstrom K. Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancer. J Clin Pathol. 2008;61:197-203.
38. Pavao M, Traish AM. Estrogen receptor antibodies: specificity and utility in detection, localization and analyses of estrogen receptor alpha and beta. Steroids. 2001;66:1-16.
39. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, Fisher KD, Mulinare J, Osterloh JD. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr. 2007;86:718-27.
40. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, Selhub J, McTiernan A, Yasui Y, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr. 2006;136:189-94.
41. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, Rosenberg IH. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007;16:1325-9.
42. Wu K, Platz EA, Willett WC, Fuchs CS, Selhub J, Rosner BA, Hunter DJ, Giovannucci E. A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr. 2009;90:1623-31.
43. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA. 2007;297:2351-9.
44. Ericson U, Sonestedt E, Gullberg B, Olsson H, Wirfalt E. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmo diet and cancer cohort. Am J Clin Nutr. 2007;86:434-43.
45. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999;340:1449-54.
46. Baggott JE, Vaughn WH, Juliana MM, Eto I, Krumdieck CL, Grubbs CJ. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst. 1992;84:1740-4.
47. Kotsopoulos J, Medline A, Renlund R, Sohn KJ, Martin R, Hwang SW, Lu S, Archer MC, Kim YI. Effects of dietary folate on the development and progression of mammary tumors in rats. Carcinogenesis. 2005;26: 1603-12.
48. Kotsopoulos J, Sohn KJ, Martin R, Choi M, Renlund R, McKerlie C, Hwang SW, Medline A, Kim YI. Dietary folate deficiency suppresses n-methyl-n- nitrosourea-induced mammary tumorigenesis in rats. Carcinogenesis. 2003;24:937-44.
49. Fazili Z, Pfeiffer CM. Measurement of folates in serum and conventionally prepared whole blood lysates: Application of an automated 96-well plate isotope-dilution tandem mass spectrometry method. Clin Chem. 2004;50:2378-81.
50. Sonestedt E, Borgquist S, Ericson U, Gullberg B, Landberg G, Olsson H, Wirfalt E. Plant foods and oestrogen receptor alpha- and beta-defined breast cancer: observations from the Malmo diet and cancer cohort. Carcinogenesis. 2008;29:2203-9.